pain
S3 celecoxib: expanding pharmacists’ options for managing musculoskeletal pain
The recent decision by the Therapeutic Goods Administration to include celecoxib 200mg as the first Schedule 3 (Pharmacist Only Medicine) selective COX-2 inhibitor in a primary pack containing not more …
Management of pelvic pain: when is it more than period pain?
As pharmacy health services for women expand, what do pharmacists need to know to differentiate pelvic pain that can be self-managed vs pain that warrants further assessment? In this webinar, …
Three-quarters of Aussie nursing home residents on regular painkillers: study
“Australia and Japan both have rapidly ageing populations but appear to have very different patterns of painkiller use,” says a pharmacist who has just examined how health professionals from both …
Efforts ‘shift the dial’ on the pain meds shortage
Steps are being made towards access to morphine oral solution – and an announcement may be on its way in the near future Mundpharma has written to advise of an …
Pharmacist voices wanted on women’s pain
Women’s pain is often overlooked, says the Victorian government – and its decision to launch an inquiry has been welcomed by pharmacists The Listening to Women’s Voices survey showed that …
Research Roundup
Debbie Rigby takes a look at the latest in research news Long-term and serious harms of medical cannabis and cannabinoids for chronic pain A systematic review and meta-analysis of 39 …
Research Roundup
Debbie Rigby takes a look at the latest in research news Cannabis-Based Products for Chronic Pain A systematic review of 18 RCTs and 7 cohort studies has concluded that oral …
Research Roundup
Debbie Rigby takes a look at the latest in research news Statin associated lower cancer risk and related mortality in patients with heart failure Patients with heart failure (HF) have …
APP2021: Annalee Combis talks about the latest trends in the VMS category
Over the past year, Australians are increasingly seeking for more holistic solutions for their wellness needs. In this interview, Annalee Combis, Marketing Lead – Wellness at GSK Consumer Healthcare talks to Miranda Deakin on the latest buyer trends in the VMS …
APP2021: James Meins talks about the growth opportunity in the pain category
The 2021 Panadol Care Study found Australians are feeling more physical pain than before, particularly among the younger generations. James Meins, Senior Marketing Manager at GSK Consumer Healthcare joined Miranda Deakin on stage at …
Endo ignorance
Despite a ministerial apology, and subsequent National Action Plan, women with endometriosis continue to experience delayed diagnosis, ongoing pain and indifference Endometriosis is a debilitating, chronic condition that affects 200 …
Research Roundup
Debbie Rigby takes a look at the latest in research news Cannabidiol as a Treatment for Chronic Pain In a US-based survey of 253 adults, most participants expressed a positive …